Literature DB >> 26796701

Effects of non-ablative fractional erbium glass laser treatment on gene regulation in human three-dimensional skin models.

Philipp M Amann1, Yvonne Marquardt2, Timm Steiner3,4, Frank Hölzle3,4, Claudia Skazik-Voogt2, Ruth Heise2, Jens M Baron5,6.   

Abstract

Clinical experiences with non-ablative fractional erbium glass laser therapy have demonstrated promising results for dermal remodelling and for the indications of striae, surgical scars and acne scars. So far, molecular effects on human skin following treatment with these laser systems have not been elucidated. Our aim was to investigate laser-induced effects on skin morphology and to analyse molecular effects on gene regulation. Therefore, human three-dimensional (3D) organotypic skin models were irradiated with non-ablative fractional erbium glass laser systems enabling qRT-PCR, microarray and histological studies at same and different time points. A decreased mRNA expression of matrix metalloproteinases (MMPs) 3 and 9 was observed 3 days after treatment. MMP3 also remained downregulated on protein level, whereas the expression of other MMPs like MMP9 was recovered or even upregulated 5 days after irradiation. Inflammatory gene regulatory responses measured by the expression of chemokine (C-X-C motif) ligands (CXCL1, 2, 5, 6) and interleukin expression (IL8) were predominantly reduced. Epidermal differentiation markers such as loricrin, filaggrin-1 and filaggrin-2 were upregulated by both tested laser optics, indicating a potential epidermal involvement. These effects were also shown on protein level in the immunofluorescence analysis. This novel standardised laser-treated human 3D skin model proves useful for monitoring time-dependent ex vivo effects of various laser systems on gene expression and human skin morphology. Our study reveals erbium glass laser-induced regulations of MMP and interleukin expression. We speculate that these alterations on gene expression level could play a role for dermal remodelling, anti-inflammatory effects and increased epidermal differentiation. Our finding may have implications for further understanding of the molecular mechanism of erbium glass laser-induced effects on human skin.

Entities:  

Keywords:  Full-thickness organotypic skin equivalents; Gene expression; Human skin reconstitution model; Laser and skin model

Mesh:

Year:  2016        PMID: 26796701     DOI: 10.1007/s10103-015-1863-x

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  31 in total

Review 1.  An overview of biological basis of pathologic scarring.

Authors:  B O Mofikoya; W L Adeyemo; A O Ugburo
Journal:  Niger Postgrad Med J       Date:  2012-03

Review 2.  The use of skin models in drug development.

Authors:  Stephanie H Mathes; Heinz Ruffner; Ursula Graf-Hausner
Journal:  Adv Drug Deliv Rev       Date:  2013-12-27       Impact factor: 15.470

3.  Treatment of cosmetic tattoos with nonablative fractional laser in an animal model: a novel method with histopathologic evidence.

Authors:  Chia-Chen Wang; Chuen-Lin Huang; Shao-Chen Lee; Yuh-Mou Sue; Fur-Jiang Leu
Journal:  Lasers Surg Med       Date:  2013-02-08       Impact factor: 4.025

4.  Non-ablative 1550-nm erbium-glass and ablative 10 600-nm carbon dioxide fractional lasers for acne scars: a randomized split-face study with blinded response evaluation.

Authors:  S B Cho; S J Lee; S Cho; S H Oh; W S Chung; J M Kang; Y K Kim; D H Kim
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-12-17       Impact factor: 6.166

5.  Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation.

Authors:  L Eckhart; W Declercq; J Ban; M Rendl; B Lengauer; C Mayer; S Lippens; P Vandenabeele; E Tschachler
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

6.  IL-31 regulates differentiation and filaggrin expression in human organotypic skin models.

Authors:  Christian Cornelissen; Yvonne Marquardt; Katharina Czaja; Jörg Wenzel; Jorge Frank; Juliane Lüscher-Firzlaff; Bernhard Lüscher; Jens M Baron
Journal:  J Allergy Clin Immunol       Date:  2011-12-15       Impact factor: 10.793

7.  Characterization of a novel standardized human three-dimensional skin wound healing model using non-sequential fractional ultrapulsed CO2 laser treatments.

Authors:  Yvonne Marquardt; Philipp M Amann; Ruth Heise; Katharina Czaja; Timm Steiner; Hans F Merk; Claudia Skazik-Voogt; Jens M Baron
Journal:  Lasers Surg Med       Date:  2015-03-15       Impact factor: 4.025

8.  Evaluation of clinical results, histological architecture, and collagen expression following treatment of mature burn scars with a fractional carbon dioxide laser.

Authors:  David M Ozog; Austin Liu; Marsha L Chaffins; Adrian H Ormsby; Edgar F Fincher; Lisa K Chipps; Qing-Sheng Mi; Peter H Grossman; John C Pui; Ronald L Moy
Journal:  JAMA Dermatol       Date:  2013-01       Impact factor: 10.282

9.  Expression and induction of cytochrome p450 isoenzymes in human skin equivalents.

Authors:  M M Neis; A Wendel; T Wiederholt; Y Marquardt; S Joussen; J M Baron; H F Merk
Journal:  Skin Pharmacol Physiol       Date:  2010-01-14       Impact factor: 3.479

10.  A study on fractional erbium glass laser therapy versus chemical peeling for the treatment of melasma in female patients.

Authors:  Neerja Puri
Journal:  J Cutan Aesthet Surg       Date:  2013-07
View more
  8 in total

Review 1.  The Northwestern Abdominoplasty Scar Model: A Tool for High-Throughput Assessment of Scar Therapeutics.

Authors:  Ji-Cheng Hsieh; Chitang J Joshi; Rou Wan; Robert D Galiano
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-29       Impact factor: 4.730

2.  Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models.

Authors:  Woan-Ruoh Lee; Shing-Chuan Shen; Calvin T Sung; Pei-Ying Liu; Jia-You Fang
Journal:  Pharm Res       Date:  2018-04-26       Impact factor: 4.200

3.  Molecular effects of fractional ablative erbium:YAG laser treatment with multiple stacked pulses on standardized human three-dimensional organotypic skin models.

Authors:  Laurenz Schmitt; P M Amann; Y Marquardt; R Heise; K Czaja; P A Gerber; T Steiner; F Hölzle; Jens Malte Baron
Journal:  Lasers Med Sci       Date:  2017-03-15       Impact factor: 3.161

4.  Deciphering the molecular effects of non-ablative Er:YAG laser treatment in an in vitro model of the non-keratinized mucous membrane.

Authors:  Laura Huth; Sebastian Huth; Yvonne Marquardt; Philipp Winterhalder; Timm Steiner; Frank Hölzle; Reinhard Gansel; Jens Malte Baron; Laurenz Schmitt
Journal:  Lasers Med Sci       Date:  2020-09-23       Impact factor: 3.161

5.  Direct biological effects of fractional ultrapulsed CO2 laser irradiation on keratinocytes and fibroblasts in human organotypic full-thickness 3D skin models.

Authors:  L Schmitt; S Huth; P M Amann; Y Marquardt; R Heise; K Fietkau; L Huth; T Steiner; F Hölzle; J M Baron
Journal:  Lasers Med Sci       Date:  2017-12-07       Impact factor: 3.161

6.  Comprehensive molecular characterization of microneedling therapy in a human three-dimensional skin model.

Authors:  Laurenz Schmitt; Yvonne Marquardt; Philipp Amann; Ruth Heise; Laura Huth; Sylvia Wagner-Schiffler; Sebastian Huth; Jens-Malte Baron
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

7.  Transcriptomic analysis of human skin wound healing and rejuvenation following ablative fractional laser treatment.

Authors:  Joseph D Sherrill; Deborah Finlay; Robert L Binder; Michael K Robinson; Xingtao Wei; Jay P Tiesman; Michael J Flagler; Wenzhu Zhao; Catherine Miller; Jean M Loftus; Alexa B Kimball; Charles C Bascom; Robert J Isfort
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

8.  MMP-3 plays a major role in calcium pantothenate-promoted wound healing after fractional ablative laser treatment.

Authors:  Sebastian Huth; Laura Huth; Yvonne Marquardt; Maria Cheremkhina; Ruth Heise; Jens Malte Baron
Journal:  Lasers Med Sci       Date:  2021-05-14       Impact factor: 3.161

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.